Notice of Lodging of Proposed Consent Decree Under the Clean Water Act, 45444-45445 [2020-16299]
Download as PDF
<![CDATA[
45444
Federal Register / Vol. 85, No. 145 / Tuesday, July 28, 2020 / Notices
39,130, 39,131 (2006); Dominick A.
Ricci, M.D., 58 FR 51,104, 51,105 (1993);
Bobby Watts, M.D., 53 FR 11,919, 11,920
(1988); Frederick Marsh Blanton, 43 FR
at 27,617.
According to California statute, ‘‘[n]o
person other than a physician . . . shall
write or issue a prescription.’’ Cal.
Health & Safety Code § 11150 (West
2020). Further, ‘‘physician,’’ as defined
by California statute, is a person who is
‘‘licensed to practice’’ in California. Id.
at § 11024.
Here, the undisputed evidence in the
record is that Registrant currently lacks
authority to practice medicine in
California. As already discussed, a
physician must be a licensed
practitioner to dispense a controlled
substance in California. Thus, because
Registrant lacks authority to practice
medicine in California and, therefore, is
not authorized to handle controlled
substances in California, Registrant is
not eligible to maintain a DEA
registration. Accordingly, I will order
that Registrant’s DEA registration be
revoked.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. AS6936201 issued to
Frederick M. Silvers, M.D. Further,
pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
823(f), I hereby deny any pending
application of Frederick M. Silvers,
M.D. to renew or modify this
registration, as well as any pending
application of Frederick M. Silvers,
M.D. for registration in California. This
Order is effective August 27, 2020.
Timothy J. Shea,
Acting Administrator.
[FR Doc. 2020–16343 Filed 7–27–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–686]
khammond on DSKJM1Z7X2PROD with NOTICES
Bulk Manufacturer of Controlled
Substances Application: Ampac Fine
Chemicals LLC
Correction
Notice document 2020–16104,
appearing on page 44924 in the issue of
Friday, July 24th, 2020, was published
as a duplicate of notice document 2020–
16104 appearing on pages 44924–44925,
and is withdrawn. Notice document
2020–16100, which should have
VerDate Sep<11>2014
16:43 Jul 27, 2020
Jkt 250001
published Friday, July 24, 2020, is
republished elsewhere in this issue.
[FR Doc. C1–2020–16104 Filed 7–27–20; 8:45 am]
BILLING CODE 1301–00–D
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–683]
Bulk Manufacturer of Controlled
Substances Application: AMPAC Fine
Chemicals Virginia, LLC
Editorial Note: Notice document 2020–
16100, which should have published Friday,
July 24, 2020, did not appear in that issue.
We are republishing it here in its entirety.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 28, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 16, 2020,
AMPAC Fine Chemicals Virginia, LLC,
2820 North Normandy Drive,
Petersburg, Virginia 23805–2380,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
Methylphenidate ......
Levomethorphan ......
Levorphanol .............
Morphine ..................
Thebaine ..................
Noroxymorphone .....
Tapentadol ...............
1724
9210
9220
9300
9333
9668
9780
Schedule
By email .......
II
II
II
II
II
II
II
By mail .........
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
[FR Doc. R1–2020–16100 Filed 7–27–20; 8:45 am]
Frm 00076
Fmt 4703
Sfmt 4703
On July 21, 2020, the Department of
Justice lodged a proposed consent
decree with the United States District
Court for the District of Hawaii in the
lawsuit entitled United States v. Pacific
Energy South West Pacific, Ltd., Civil
Action No. 20–CV–322.
The United States filed this lawsuit
under the Clean Water Act. The United
States’ complaint seeks injunctive relief
and civil penalties for violations of a
National Pollutant Discharge
Elimination System permit, violations of
an administrative order issued by the
United States Environmental Protection
Agency, and unpermitted discharges of
pollutants to waters of the United States
at the American Samoa Terminal, a fuel
terminal that the defendant Pacific
Energy South West Pacific, Ltd.,
operates in Pago Pago, American Samoa.
The consent decree requires the
defendant to perform injunctive relief
and pay a $300,000 civil penalty.
The publication of this notice opens
a period for public comment on the
consent decree. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States v. Pacific Energy South
West Pacific, Ltd., D.J. Ref. No. 90–5–1–
1–12086. All comments must be
submitted no later than thirty (30) days
after the publication date of this notice.
Comments may be submitted either by
email or by mail:
Send them to:
William T. McDermott,
Assistant Administrator.
PO 00000
Notice of Lodging of Proposed
Consent Decree Under the Clean Water
Act
To submit
comments:
The company plans to manufacture
the above-listed controlled substances
in bulk for distribution to its customers.
No other activities for these drug codes
are authorized for this registration.
BILLING CODE 1301–00–D
DEPARTMENT OF JUSTICE
During the public comment period,
the consent decree may be examined
and downloaded at this Justice
Department website: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
consent decree upon written request
and payment of reproduction costs.
Please mail your request and payment
to: Consent Decree Library, U.S. DOJ—
ENRD, P.O. Box 7611, Washington, DC
20044–7611.
Please enclose a check or money order
for $11.50 (25 cents per page
E:\FR\FM\28JYN1.SGM
28JYN1
Federal Register / Vol. 85, No. 145 / Tuesday, July 28, 2020 / Notices
regulatory process for the development
of drugs and devices; an update on the
NRC’s Phase 2 revision of Regulatory
Henry Friedman,
Guide 8.39, ‘‘Release of Patients
Assistant Section Chief, Environmental
Administered Radioactive Material’’;
Enforcement Section, Environment and
and an update on the activities of the
Natural Resources Division.
NRC’s Medical Radiation Safety Team.
[FR Doc. 2020–16299 Filed 7–27–20; 8:45 am]
The agenda is subject to change. The
BILLING CODE 4410–15–P
current agenda and any updates will be
available on the ACMUI’s Meetings and
Related Documents web page at https://
NATIONAL CREDIT UNION
www.nrc.gov/reading-rm/docADMINISTRATION
collections/acmui/meetings/2020.html
or by emailing Ms. Kellee Jamerson at
Sunshine Act Meeting
the contact information below.
Purpose: Discuss issues related to 10
SUMMARY: Due to the COVID–19
CFR
part 35 Medical Use of Byproduct
Pandemic, the meeting will be open to
Material.
the public via live webcast only. Visit
Date and Time for Open Sessions:
the agency’s homepage (www.ncua.gov.)
September 21, 2020, from 10 a.m. to 2
and access the provided webcast link.
p.m. and September 22, 2020, from
DATES: 10 a.m., Thursday, July 30, 2020.
12:15 p.m. to 1:45 p.m. Eastern Standard
STATUS: This meeting will be open to the Time (EST).
public.
Date
Webinar information
MATTERS TO BE CONSIDERED:
1. NCUA Rules and Regulations,
September 21, Link: https://
Chartering and Field of Membership.
2020.
usnrc.webex.com.
2. NCUA Rules and Regulations,
Event number: 199 744
Transition to CECL Methodology.
7681.
3. NCUA Rules and Regulations, Fees September 22, Link: https://
Paid By Federal Credit Unions.
2020.
usnrc.webex.com.
4. Request for Comment, Overhead
Event number: 199 319
2198.
Transfer Rate and Operating Fee
Methodologies.
Date and Time for Closed Session:
5. Board Briefing, 2020 Mid-Session
September 22, 2020, from 10 a.m. to 12
Budget.
p.m. EST. This session will be closed to
CONTACT PERSON FOR MORE INFORMATION:
Gerard Poliquin, Secretary of the Board, conduct the ACMUI’s required annual
training.
Telephone: 703–518–6304.
Public Participation: The meeting will
Gerard Poliquin,
be held as a webinar using the WebEx
meeting platform. Any member of the
Secretary of the Board.
public who wishes to participate in any
[FR Doc. 2020–16366 Filed 7–24–20; 11:15 am]
open sessions of this meeting should
BILLING CODE 7535–01–P
register in advance of the meeting by
visiting the link and entering the event
number(s) provided above. Upon
NUCLEAR REGULATORY
successful registration, a confirmation
COMMISSION
email will be generated providing the
telephone bridge line and a link to join
Advisory Committee on the Medical
the webinar on the day of the meeting.
Uses of Isotopes: Meeting Notice
Members of the public should also
AGENCY: U.S. Nuclear Regulatory
monitor the NRC’s Public Meeting
Commission.
Schedule at https://www.nrc.gov/pmns/
mtg for any meeting updates. If there are
ACTION: Notice of meeting.
any questions regarding the meeting,
SUMMARY: The U.S. Nuclear Regulatory
persons should contact Ms. Jamerson
Commission (NRC) will convene a
using the information below.
meeting of the Advisory Committee on
Contact Information: Ms. Kellee
the Medical Uses of Isotopes (ACMUI)
Jamerson, email: Kellee.Jamerson@
on September 21–22, 2020. A sample of nrc.gov, telephone: 301–415–7408.
agenda items to be discussed during the
public session includes: A discussion of Conduct of the Meeting
Darlene F. Metter, M.D. will chair the
the ACMUI’s review and analysis of
meeting. Dr. Metter will conduct the
medical events from fiscal year 2019; a
meeting in a manner that will facilitate
discussion of the ACMUI’s review and
the orderly conduct of business. The
analysis of non-medical events from
following procedures apply to public
fiscal year 2019; a discussion on the
participation in the meeting:
U.S. Food and Drug Administration’s
khammond on DSKJM1Z7X2PROD with NOTICES
reproduction cost) payable to the United
States Treasury.
VerDate Sep<11>2014
16:43 Jul 27, 2020
Jkt 250001
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
45445
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. Jamerson using
the contact information listed above. All
submittals must be received by the close
of business on September 15, 2020,
three business days before the meeting,
and must pertain to the topics on the
agenda for the meeting.
2. Questions and comments from
members of the public will be permitted
during the meeting, at the discretion of
the Chairman.
3. The draft transcript and meeting
summary will be available on ACMUI’s
website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2020.html on or about November 6,
2020.
4. Persons who require special
services, such as those for the hearing
impaired, should notify Ms. Jamerson of
their planned participation.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in title 10 of
the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland, this 23rd day
of July, 2020.
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Federal Advisory Committee Management
Officer.
[FR Doc. 2020–16290 Filed 7–27–20; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2020–0168]
Biweekly Notice; Applications and
Amendments to Facility Operating
Licenses and Combined Licenses
Involving No Significant Hazards
Considerations
Nuclear Regulatory
Commission.
ACTION: Biweekly notice.
AGENCY:
Pursuant to section 189.a.(2)
of the Atomic Energy Act of 1954, as
amended (the Act), the U.S. Nuclear
Regulatory Commission (NRC) is
publishing this regular biweekly notice.
The Act requires the Commission to
publish notice of any amendments
issued, or proposed to be issued, and
grants the Commission the authority to
issue and make immediately effective
any amendment to an operating license
or combined license, as applicable,
upon a determination by the
SUMMARY:
E:\FR\FM\28JYN1.SGM
28JYN1
]]>Agencies
[Federal Register Volume 85, Number 145 (Tuesday, July 28, 2020)]
[Notices]
[Pages 45444-45445]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16299]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed Consent Decree Under the Clean
Water Act
On July 21, 2020, the Department of Justice lodged a proposed
consent decree with the United States District Court for the District
of Hawaii in the lawsuit entitled United States v. Pacific Energy South
West Pacific, Ltd., Civil Action No. 20-CV-322.
The United States filed this lawsuit under the Clean Water Act. The
United States' complaint seeks injunctive relief and civil penalties
for violations of a National Pollutant Discharge Elimination System
permit, violations of an administrative order issued by the United
States Environmental Protection Agency, and unpermitted discharges of
pollutants to waters of the United States at the American Samoa
Terminal, a fuel terminal that the defendant Pacific Energy South West
Pacific, Ltd., operates in Pago Pago, American Samoa. The consent
decree requires the defendant to perform injunctive relief and pay a
$300,000 civil penalty.
The publication of this notice opens a period for public comment on
the consent decree. Comments should be addressed to the Assistant
Attorney General, Environment and Natural Resources Division, and
should refer to United States v. Pacific Energy South West Pacific,
Ltd., D.J. Ref. No. 90-5-1-1-12086. All comments must be submitted no
later than thirty (30) days after the publication date of this notice.
Comments may be submitted either by email or by mail:
------------------------------------------------------------------------
To submit comments: Send them to:
------------------------------------------------------------------------
By email............................ [email protected].
By mail............................. Assistant Attorney General, U.S.
DOJ--ENRD, P.O. Box 7611,
Washington, DC 20044-7611.
------------------------------------------------------------------------
During the public comment period, the consent decree may be
examined and downloaded at this Justice Department website: https://www.justice.gov/enrd/consent-decrees. We will provide a paper copy of
the consent decree upon written request and payment of reproduction
costs. Please mail your request and payment to: Consent Decree Library,
U.S. DOJ--ENRD, P.O. Box 7611, Washington, DC 20044-7611.
Please enclose a check or money order for $11.50 (25 cents per page
[[Page 45445]]
reproduction cost) payable to the United States Treasury.
Henry Friedman,
Assistant Section Chief, Environmental Enforcement Section, Environment
and Natural Resources Division.
[FR Doc. 2020-16299 Filed 7-27-20; 8:45 am]
BILLING CODE 4410-15-P
